EGFR and cancer: Some well-known signaling pathways, such as MAPK, EGFR/HER, CDK, and Cadherin–catenin complex, are major cell cycle players and deregulation of their phosphorylation–dephosphorylation activity has been shown to lead to the formation of various types of cancers.